by Frank Sorce | Mar 6, 2024 | Blog, Medical Writing, Nancy Smith
Welcome to the essential yet often behind-the-scenes world of regulatory medical writing. This field stands at the crossroads of science and communication for the approval of new medical treatments. Regulatory writers are the linchpins in this process, tasked with...
by Frank Sorce | Feb 20, 2024 | Case Studies
ABOUT The client is a clinical-stage biotechnology company focused on the phase III development of an anti-interleukin-6 monoclonal antibody therapeutic for the potential treatment of chronic active antibody-mediated rejection, the leading cause of long-term rejection...
by Frank Sorce | Feb 13, 2024 | Case Studies
ABOUT The client is a U.S.-based clinical-stage biotechnology company using artificial intelligence (AI) and human data to transform drug discovery and development. The company uses machine learning to map the complex causes of diseases to develop proprietary drug...
by Frank Sorce | Jan 22, 2024 | Case Studies
ABOUT The client is an emerging biotechnology company focused on developing and commercializing patient-friendly compounds to treat psychiatric and neurological disorders. The company is developing breakthrough non-hallucinogenic psychedelic derivatives with the...
by Frank Sorce | Jan 19, 2023 | Press Releases
Expands Expertise in Biologics and Builds Scale in CMC and Quality Consulting Boston, MA, January 19, 2023 – Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and...